Jazz Pharmaceuticals plc — Director's Dealing 2014

Aug 7, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-07-31

Reporting Person: McGill Iain (Head of EUSA Int'l & SVP)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	27553	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Nonstatutory Stock Option (right to buy)	$46.83	2022-08-08	Ordinary Shares (22500)		Direct
Nonstatutory Stock Option (right to buy)	$59.13	2023-03-04	Ordinary Shares (8500)		Direct
Nonstatutory Stock Option (right to buy)	$166.62	2024-02-26	Ordinary Shares (11500)		Direct

Footnotes

F1: Including 25,250 restricted stock units ("RSUs") granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share upon the vesting of the unit. Of the 25,250 RSUs, 15,000 RSUs vest in three equal annual installments from August 9, 2014 to August 9, 2016, 4,500 RSUs vest in three equal annual installments from March 5, 2015 to March 5, 2017, and 5,750 RSUs vest in four equall annual installments from February 27, 2015 to February 27, 2018.

F2: This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested with respect to 1,666 shares and vest with respect to 20,834 shares in equal monthly installments from August 9, 2014 to August 9, 2016.

F3: This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested with respect to 750 shares and vest with respect to 7,750 shares in equal monthly installments from September 5, 2014 to March 5, 2017.

F4: This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. 1/4th of the ordinary shares subject to this option vest on February 27, 2015 and the remainder vest in equal monthly installments from March 27, 2015 to February 27, 2018.